Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027627 (metastases)
 103,950 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Spontaneous pneumothorax is an uncommon complication of lung metastatic disease. In most of the cases reported until today, the primary disease was a sarcoma (osteogenic sarcoma, soft tissue sarcoma, hemangioendotheliosarcoma, and Ewing's sarcoma). An exceptional case of spontaneous pneumothorax in a patient suffering from carcinoma of the breast with lung metastases, is herein presented. The pneumothorax developed immediately after regression of lung metastases during administration of combined chemotherapy. Some etiological factors, as well as the rarity of this complication and its treatment, are also discussed.
 ...
PMID:Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast. 83 Mar 15

A study was made of 24 children under 15 years with thyroid cancer diagnosed during the years 1959-1967. None of the children had received irradiation treatment prior to diagnosis. Treatment took the form of surgery in combination with hormone and/or irradiation therapy. Of the 24 patients, only one died as a result of postoperative complications, even though 17% had lung metastases and 58% lymph gland metastases. The children were observed on average seven years, 10 months and the longest period of observation was 12 years, six months. The treatment recommended is total lobectomy on the affected side and subtotal on the opposite side. Cervical lymph glands with metastases are extirpated. Thyroid hormone treatment should be given immediately after surgery.
 ...
PMID:Thyroid carcinoma in children. 84 65

The response of lung metastases of the Lewis lung tumor to a single dose of cyclophosphamide (300 mg/kg) has been studied as a function of the size of the metastases. Both artificially induced and naturally arising (true) metastases were studied in the absence of a primary tumor. It was found that the artificial metastases exhibited a change in cure probability from 90% to 37% over a size range of a factor of ten. The true metastases had a larger spread in size for a similar change in cure probability but there were large uncertainties in the data and consequently the results are not inconsistent with those for the artificial metastases. Studies of the cell kinetics of the metastases at various sizes in the critical range for curability failed to demonstrate any marked differences. It was concluded that the results of drug treatment could be explained entirely on the basis of an increase in cell number in the larger metastases.
 ...
PMID:Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes. 86 61

During the last 10 years the authors operated upon 8 patients with illnesses beginning with different lung alterations. In all cases the basic illness was a papillary or papillo-follicular cancer of the thyroid gland which later was found indirectly after other operation and histologic examination. By evaluation of clinical symptoms, operative and morphologic findings conclusions as well as the results of reexamination the authors draw conclusions as to the biological attributes of this tumor type. They recognize that the carcinomas of the thyroid gland cause metastases of regional lymph nodes or distant lung metastases approaching the TO stage. Lung metastases appeared in different shapes and were in all cases the fist clinical sign of the basic illness. Considering the biological attributes of this tumor the authors emphasize that it is not inoperable or untreatable.
 ...
PMID:[The unrecognized thyroid neoplasm]. 86 81

Artificial pulmonary metastases of a mouse fibrosarcoma were produced by the intravenous injection of 10(4) cells admixed with 2 X 10(6) plastic microspheres into mice preconditioned with 600 rad whole-body irradiation 24 hours earlier. Four days after injection of tumour cells, mice were irradiated with neutrons generated by 50 MeV deuterons on Be at the Texas A & M Variable Energy Cyclotron or with 137Cs gamma rays. One, three or six fractions of radiation were delivered on a three-hour fractionation schedule. Surviving lung metastases were scored macroscopically 16 days after irradiation. The data indicate that: (1) the RBE (n/gamma) was in the range 1.6-2.6 depending on the size of dose per fraction; (2) the slopes of the gamma-ray curves decreased with increasing fraction number (i.e. decreasing fraction size); (3) the slopes of the neutron curves decreased only slightly with increasing fraction number (and decreasing fraction size); (4) no additional sparing was achieved by further fractionating doses of neutrons of 300 rad or less.
 ...
PMID:RBE of neutrons generated by 50 MeV deuterons on beryllium for control of artificial pulmonary metastases of a mouse fibrosarcoma. 90 77

The Madison 109 (M109) tumor was discovered in 1964 in the lung of a BALB/c mouse. This experimental carcinoma is maintained in vivo by sc passage in the right axillary region. When implanted im (5 X 10(5) cells) into the right hind leg of BALB/c mice for testing, the primary progresses with metastases to the lung, spleen, and liver. The metastases to the lung are visible within 3 weeks and result in the death of the host in about 35 days after tumor implant. Implantation of a lung nodule is tumorigenic and lethal. Pyran polymer therapy delayed the appearance of lung metastases, inhibited the growth of the primary tumor, and significantly increased the lifespan of BALB/c mice inoculated with the M109 tumor. No spontaneous regression has been observed and very few "no takes" have occurred in untreated BALB/c mice inoculated with at least 500 M109 cells. Of the 82 agents tested so far, the M109 model has selected active agents such as actinomycin D, adriamycin, daunorubicin, DNA, procarbazine, and pyran polymer. It has not shown sensitivity as tested to several standard therapeutic agents including cytosine arabinoside, BCNU, hydroxyurea, mechlorethamine, melphalan, triethylenemelamine, and vincristine.
 ...
PMID:Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. 92 51

Spontaneous remission of pulmonary metastases from renal cell carcinoma was correlated with a positive response to dinitrochlorobenzene (DNCB). When first seen, the patient was DNCB negative and a chest radiograph showed nodular densities in the right lung and left midlung. Six months after sensitization, the patient had a positive response to DNCB and no evidence of lung metastases. Three mo later, the patient developed brain metastases although X-ray examination showed no pulmonary nodules. A diminished response to DNCB noted over the next several months and chest X ray verified the return of pulmonary metastases.
 ...
PMID:Immunocompetence and spontaneous regression of metastatic renal cell carcinoma. 93 43

Noncurative excision of a primary sc Lewis lung tumor performed on Day 7 or later results in an increase in the thymidine index and growth rate with minimal changes in the cell cycle parameters of the lung metastases. The stimulation of the lung nodules is accompanied by a small but consistent decrease in median lifespan. Sham surgery performed on Day 3 or later also results in a decrease in median lifespan and an increase in the thymidine index of the undisturbed primary tumor. Artifical metastases (10(6) cells iv) are inhibited by the presence of a second (sc) implant and the median lifespan of the doubly implanted mice exceeds that of mice bearing iv implants only. In mice bearing widely metastasized Lewis lung carcinoma, surgery alone may have a detrimental effect on life expectancy, but the residual tumor foci, stimulated to more rapid growth, should be appropriate targets for adjuvant chemotherapy.
 ...
PMID:Effects of surgery on the cell kinetics of residual tumor. 102 33

The paper presents a detailed comparison of the anatomical distribution and frequency of clinically evident metastases in 152 cases of osteosarcoma, and autopsy findings in 43 cases. The behaviour of long bone tumours is contrasted with those arising elsewhere, which tend to metastasize less widely because of early death from effects of the primary tumour. In both clinical and autopsy series long bone tumours produced lung metastases (LM) in over 90% of patients dying with metastases, but the terminal frequency of extra-pulmonary metastases (EPM) rises from a clinical level of 33% to 83% at autopsy. There was little difference between tumours of the major long bones in the frequency of either LM or EPM, but EPM from the humerus tended to be fewer and sited above the diaphragm and from the femur below it. EPM most often involved other bones, notably vertebrae and pelvis. Not more than 10% of tumours invaded regional lymph nodes but terminally a quarter of the long bone tumours had metastasized to heart and abdomen. The infrequency of metastases in muscle was confirmed. The median time for LM was 5-6 months after starting treatment, for EPM 9-10. months. First metastases after 24 months were infrequent, especially in children. With delay in the appearance of metastases, whether LM or EPM, post-metastatic survival lengthened. Neither age, sex nor mode of treatment of the primary notably affected metastatic frequency, although recurrences were much more numerous when radiotherapy, even with high dosage, was the definitive treatment. Local recurrence usually appeared within 6-8 months and was shown to lead to increased frequency of osseous metastases. It is suggested that terminal dissemination may often be tertiary but not always from a pulmonary secondary.
 ...
PMID:The metastatic patterns of osteosarcoma. 105 38

Pulmonary metastases were measured in 7 patients with osteosarcoma. The growth curve of these metastases appears to conform closely to a Gompertzian function, a mathematical description widely accepted as a model for tumor growth in animal systems. Growth curves for pulmonary metastases were projected backwards assuming exponential growth for that period between amputation and initial roentgenologic detection. Lesion size at the time of amputation is estimated and found to vary widely from miniscule lesions of a few cells to large foci destined to become roentgenographically detectable within a few weeks of amputation.
 ...
PMID:Growth characteristics of pulmonary metastases from osteosarcoma. 106 97


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>